Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Mangoceuticals (MGRX)

Mangoceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MGRX
DateTimeSourceHeadlineSymbolCompany
19/12/202422:33GlobeNewswire Inc.Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations PatentNASDAQ:MGRXMangoceuticals Inc
19/12/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
06/12/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
04/12/202412:00GlobeNewswire Inc.Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock SplitNASDAQ:MGRXMangoceuticals Inc
14/11/202421:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGRXMangoceuticals Inc
12/11/202422:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
31/10/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
31/10/202412:00GlobeNewswire Inc.Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:MGRXMangoceuticals Inc
25/10/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
22/10/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
22/10/202412:00GlobeNewswire Inc.MangoRx Announces Formation of Strategy and Alternatives CommitteeNASDAQ:MGRXMangoceuticals Inc
21/10/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
21/10/202421:10GlobeNewswire Inc.MangoRx Responds to and Refutes Recent Claims Made by Eli LillyNASDAQ:MGRXMangoceuticals Inc
11/10/202421:15GlobeNewswire Inc.MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLANNASDAQ:MGRXMangoceuticals Inc
03/10/202412:30GlobeNewswire Inc.MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss SolutionsNASDAQ:MGRXMangoceuticals Inc
01/10/202417:05AllPennyStocks.comHealthcare Shares Rise Following Product Availability AnnouncementNASDAQ:MGRXMangoceuticals Inc
01/10/202411:30GlobeNewswire Inc.MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss TreatmentNASDAQ:MGRXMangoceuticals Inc
15/08/202413:25GlobeNewswire Inc.MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024NASDAQ:MGRXMangoceuticals Inc
13/08/202420:00GlobeNewswire Inc.MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology PatentNASDAQ:MGRXMangoceuticals Inc
09/08/202412:15GlobeNewswire Inc.MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and TirzepatideNASDAQ:MGRXMangoceuticals Inc
24/07/202412:15GlobeNewswire Inc.MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention TechnologyNASDAQ:MGRXMangoceuticals Inc
18/07/202420:05GlobeNewswire Inc.Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-AccessNASDAQ:MGRXMangoceuticals Inc
16/07/202412:20GlobeNewswire Inc.MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via SurescriptsNASDAQ:MGRXMangoceuticals Inc
12/07/202417:30GlobeNewswire Inc.MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation DepartmentNASDAQ:MGRXMangoceuticals Inc
11/07/202412:15GlobeNewswire Inc.MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging MarketsNASDAQ:MGRXMangoceuticals Inc
18/06/202418:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGRXMangoceuticals Inc
10/06/202417:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGRXMangoceuticals Inc
06/06/202412:30GlobeNewswire Inc.MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care TechnologyNASDAQ:MGRXMangoceuticals Inc
05/06/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
05/06/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGRXMangoceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MGRX